- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6750
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Tuning the performance of CAR T cell immunotherapies ; volume:19 ; number:1 ; day:29 ; month:11 ; year:2019 ; pages:1-7 ; date:12.2019
BMC biotechnology ; 19, Heft 1 (29.11.2019), 1-7, 12.2019
- Urheber
-
Richardson, Noah H.
Luttrell, Jordan B.
Bryant, Jonathan S.
Chamberlain, Damian
Khawaja, Saleem
Neeli, Indira
Radic, Marko
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12896-019-0576-9
- URN
-
urn:nbn:de:101:1-2020032423424623976175
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Richardson, Noah H.
- Luttrell, Jordan B.
- Bryant, Jonathan S.
- Chamberlain, Damian
- Khawaja, Saleem
- Neeli, Indira
- Radic, Marko
- SpringerLink (Online service)
Ähnliche Objekte (12)
Fine-tuning anti-tumor immunotherapies via stochastic simulations
Bispecific antibodies and CAR-T cells: dueling immunotherapies for large B-cell lymphomas
CAR-Immunotherapies for the treatment of metastatic rhabdomyosarcomas
Prospects for Development of Induced Pluripotent Stem Cell-Derived CAR-Targeted Immunotherapies
Dynamic fine-tuning of CAR-T cell therapy
Dynamic fine-tuning of CAR-T cell therapy
Safety profile of chimeric antigen receptor T-cell immunotherapies (CAR-T) in clinical practice
A deep insight into CRISPR/Cas9 application in CAR-T cell-based tumor immunotherapies
Neurological complications associated with cancer immunotherapies - allogeneic stem cell transplantation, immune checkpoint inhibition, and CAR T cell therapy
Synthetic Cell-Based Immunotherapies for Neurologic Diseases
Molecular imaging biomarkers for cell-based immunotherapies
Dual-targeted CAR T-cell immunotherapies for hematological malignancies: latest updates from the 2023 ASH annual meeting
Fine-tuning anti-tumor immunotherapies via stochastic simulations
Bispecific antibodies and CAR-T cells: dueling immunotherapies for large B-cell lymphomas
CAR-Immunotherapies for the treatment of metastatic rhabdomyosarcomas
Prospects for Development of Induced Pluripotent Stem Cell-Derived CAR-Targeted Immunotherapies
Dynamic fine-tuning of CAR-T cell therapy
Dynamic fine-tuning of CAR-T cell therapy
Safety profile of chimeric antigen receptor T-cell immunotherapies (CAR-T) in clinical practice
A deep insight into CRISPR/Cas9 application in CAR-T cell-based tumor immunotherapies
Neurological complications associated with cancer immunotherapies - allogeneic stem cell transplantation, immune checkpoint inhibition, and CAR T cell therapy
Synthetic Cell-Based Immunotherapies for Neurologic Diseases
Molecular imaging biomarkers for cell-based immunotherapies
Dual-targeted CAR T-cell immunotherapies for hematological malignancies: latest updates from the 2023 ASH annual meeting
Fine-tuning anti-tumor immunotherapies via stochastic simulations
Bispecific antibodies and CAR-T cells: dueling immunotherapies for large B-cell lymphomas
CAR-Immunotherapies for the treatment of metastatic rhabdomyosarcomas
Prospects for Development of Induced Pluripotent Stem Cell-Derived CAR-Targeted Immunotherapies
Dynamic fine-tuning of CAR-T cell therapy
Dynamic fine-tuning of CAR-T cell therapy
Safety profile of chimeric antigen receptor T-cell immunotherapies (CAR-T) in clinical practice
A deep insight into CRISPR/Cas9 application in CAR-T cell-based tumor immunotherapies
Neurological complications associated with cancer immunotherapies - allogeneic stem cell transplantation, immune checkpoint inhibition, and CAR T cell therapy
Synthetic Cell-Based Immunotherapies for Neurologic Diseases
Molecular imaging biomarkers for cell-based immunotherapies